📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
2 articles
AVG GRADE
NEUTRAL
score: 0.00
SENTIMENT
NEUTRAL
TOTAL VIEWS
20
ZNTL Latest News & AI Sentiment Analysis
2 articles · Grade: NEUTRAL · Real-time AI-graded coverage
RECENT COVERAGE · 3 ARTICLES
Zentalis Pharmaceuticals Announces Pricing of Underwritten Public Offering
Zentalis Pharmaceuticals announced pricing of an underwritten public offering of 23 million shares at $3.50 per share, generating...
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Zentalis Pharmaceuticals (ZNTL) announced routine inducement grants of 84,000 non-qualified stock options to two newly hired employees...
Zentalis Pharmaceuticals to Present at the European Society for Medical Oncology (ESMO) Congress 2026
Zentalis Pharmaceuticals (ZNTL) announced two presentations at the October 2026 ESMO Congress, including a rapid oral presentation...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice